These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7153101)

  • 1. Therapeutic implications of iodine-125 cytotoxicity.
    Bloomer WD; McLaughlin WH; Adelstein SJ
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1903-8. PubMed ID: 7153101
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic applications of Auger and alpha emitting radionuclides.
    Bloomer WD; McLaughlin WH; Adelstein SJ; Wolf AP
    Strahlentherapie; 1984 Dec; 160(12):755-7. PubMed ID: 6393458
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiation biology and potential therapeutic applications of radionuclides.
    Hofer KG
    Bull Cancer; 1980; 67(3):343-53. PubMed ID: 7407434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-125 cytotoxicity: implications for therapy and estimation of radiation risk.
    Bloomer WD; Adelstein SJ
    Int J Nucl Med Biol; 1981; 8(2-3):171-8. PubMed ID: 7033155
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters.
    Bloomer WD; Adelstein SJ
    Nature; 1977 Feb; 265(5595):620-1. PubMed ID: 859560
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential for tumor therapy with iodine-125 labeled immunoglobulins.
    Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S
    Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-125-labelled tamoxifen is differentially cytoxic to cells containing oestrogen receptors.
    Bloomer WD; McLaughlin WH; Weichselbaum RR; Tonnesen GL; Hellman S; Seitz DE; Hanson RN; Adelstein SJ; Rosner AL; Burstein NA; Nove JJ; Little JB
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Aug; 38(2):197-202. PubMed ID: 6968738
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Antineoplastic effect of iodine-125-labelled iododeoxyuridine.
    Bloomer WD; Adelstein SJ
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):509-11. PubMed ID: 1080145
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen receptor-mediated cytotoxicity using iodine-125.
    Bloomer WD; McLaughlin WH; Milius RA; Weichselbaum RR; Adelstein SJ
    J Cell Biochem; 1983; 21(1):39-45. PubMed ID: 6874726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiochemotherapy with 125I-5-iodo-2-deoxyuridine.
    Bagshawe KD
    Cancer Treat Rev; 1987 Dec; 14(3-4):397-9. PubMed ID: 3440257
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhomogeneity of the nucleus to 125IUdR cytotoxicity.
    Yasui LS; Hofer KG; Warters RL
    Radiat Res; 1985 Apr; 102(1):106-18. PubMed ID: 3920724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy.
    Bloomer WD; Adelstein SJ
    Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell survival and cytogenetic responses to 125I-UdR in cultured mammalian cells.
    Chan PC; Lisco E; Lisco H; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):426-35. PubMed ID: 565273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA uptake of 131I-iododeoxyuridine.
    Baranowska-Kortylewicz J; Nearman J
    J Nucl Med; 2005 May; 46(5):898-9. PubMed ID: 15872365
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine.
    Kassis AI; Guptill WE; Taube RA; Adelstein SJ
    J Nucl Biol Med (1991); 1991; 35(3):167-73. PubMed ID: 1840093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical animal studies with radioiododeoxyuridine.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with encapsulated 125I sources. II. Determination of the relative biological effectiveness using cultured mammalian cells.
    Freeman ML; Goldhagen P; Sierra E; Hall EJ
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1355-61. PubMed ID: 7141915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells.
    Kassis AI; Fayad F; Kinsey BM; Sastry KS; Adelstein SJ
    Radiat Res; 1989 May; 118(2):283-94. PubMed ID: 2727257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?
    Adelstein SJ
    AJR Am J Roentgenol; 1993 Apr; 160(4):707-13. PubMed ID: 8456649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.